Contact information
Websites
Alastair Smith
Postdoctoral Researcher
Brief biography and current research interests
I joined the Milne Lab in 2018 after completing my PhD, where I investigated the temporal regulation of transcription in V(D)J recombination. My current research focuses on the emergence and function of novel enhancers in leukaemia, with a particular emphasis on MLL-AF4 Acute Lymphoblastic Leukaemia (ALL).
To investigate chromatin regulation and gene expression, I apply a broad suite of high-throughput and integrative approaches. These include ChIP-seq, low-input ChIPmentation, ATAC-seq, RNA-seq, Capture-C, CUT&Tag, single-cell multiomics, and DNA methylation profiling. I combine these data with machine learning and advanced bioinformatic methods to uncover mechanisms of transcriptional dysregulation in leukaemia.
Recent publications
-
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL.
Journal article
Cross JW. et al, (2025), Blood Adv
-
Iron deficiency causes aspartate-sensitive dysfunction in CD8+ T cells.
Journal article
Teh MR. et al, (2025), Nat Commun, 16
-
A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features.
Journal article
Bueno C. et al, (2023), Blood
-
Temporal analyses reveal a pivotal role for sense and antisense enhancer RNAs in coordinate immunoglobulin lambda locus activation.
Journal article
Gao Z. et al, (2023), Nucleic Acids Res
-
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Journal article
Crump NT. et al, (2023), Nat Commun, 14